Cargando…
Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244681/ https://www.ncbi.nlm.nih.gov/pubmed/27671365 http://dx.doi.org/10.1111/tmi.12784 |
| _version_ | 1782496737873625088 |
|---|---|
| author | Ravinetto, Raffaella De Weggheleire, Anja Dorlo, Thomas P.C. Francque, Sven Sokkab, An Pouget, Corinne Meessen, Bruno Tabernero, Patricia Newton, Paul N. Lynen, Lut |
| author_facet | Ravinetto, Raffaella De Weggheleire, Anja Dorlo, Thomas P.C. Francque, Sven Sokkab, An Pouget, Corinne Meessen, Bruno Tabernero, Patricia Newton, Paul N. Lynen, Lut |
| author_sort | Ravinetto, Raffaella |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5244681 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52446812017-01-25 Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint Ravinetto, Raffaella De Weggheleire, Anja Dorlo, Thomas P.C. Francque, Sven Sokkab, An Pouget, Corinne Meessen, Bruno Tabernero, Patricia Newton, Paul N. Lynen, Lut Trop Med Int Health Editorial John Wiley and Sons Inc. 2016-10-17 2016-12 /pmc/articles/PMC5244681/ /pubmed/27671365 http://dx.doi.org/10.1111/tmi.12784 Text en © 2016 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Ravinetto, Raffaella De Weggheleire, Anja Dorlo, Thomas P.C. Francque, Sven Sokkab, An Pouget, Corinne Meessen, Bruno Tabernero, Patricia Newton, Paul N. Lynen, Lut Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint |
| title | Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint |
| title_full | Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint |
| title_fullStr | Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint |
| title_full_unstemmed | Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint |
| title_short | Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint |
| title_sort | predictable threats to public health through delaying universal access to innovative medicines for hepatitis c: a pharmaceutical standpoint |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244681/ https://www.ncbi.nlm.nih.gov/pubmed/27671365 http://dx.doi.org/10.1111/tmi.12784 |
| work_keys_str_mv | AT ravinettoraffaella predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT deweggheleireanja predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT dorlothomaspc predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT francquesven predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT sokkaban predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT pougetcorinne predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT meessenbruno predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT taberneropatricia predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT newtonpauln predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint AT lynenlut predictablethreatstopublichealththroughdelayinguniversalaccesstoinnovativemedicinesforhepatitiscapharmaceuticalstandpoint |